What is the workup for muscle pain (myalgia)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The workup for myalgia should include a complete rheumatologic and neurologic history, examination of muscle strength, and blood testing to evaluate muscle inflammation, as recommended by the American Society of Clinical Oncology clinical practice guideline 1. The diagnostic work-up should comprise the following key components:

  • A thorough history and physical examination to identify potential causes and consider preexisting conditions that can cause similar symptoms
  • Blood testing, including:
    • Creatine kinase (CK) to assess muscle damage
    • Transaminases (AST, ALT), lactate dehydrogenase (LDH), and aldolase to evaluate muscle inflammation
    • Troponin to evaluate myocardial involvement
    • Inflammatory markers (ESR and CRP) to assess for inflammation
  • Additional testing, such as electromyography (EMG), imaging (MRI), and/or biopsy, may be considered on an individual basis when diagnosis is uncertain or overlap with neurologic syndromes is suspected 1. It is essential to tailor the workup to the clinical presentation, considering medication review and potential systemic conditions, such as polymyalgia rheumatica, fibromyalgia, and viral infections, based on accompanying symptoms. The American Society of Clinical Oncology clinical practice guideline recommends monitoring CK, ESR, and CRP levels to assess treatment response and disease progression 1.

From the FDA Drug Label

The FDA drug label does not answer the question.

From the Research

Diagnostic Approach for Myalgia

The diagnostic approach for myalgia involves a combination of laboratory tests, physical examinations, and medical history.

  • Initial screening tests include creatine kinase and erythrocyte sedimentation rate (ESR) 2
  • If either of these tests is abnormal, further investigations such as muscle biopsy, electromyography, muscle strength, and exercise testing may be performed 2
  • Other laboratory tests that may be useful in diagnosing myalgia include C-reactive protein (CRP) and interleukin-6 levels 3

Specific Conditions that May Cause Myalgia

Several specific conditions may cause myalgia, including:

  • Post-infection myositis, which may occur after a viral infection and is characterized by severe myalgia and muscle weakness in the proximal muscles of the lower limbs 3
  • Polymyalgia rheumatica (PMR), a common inflammatory disorder characterized by myalgia and stiffness in the proximal hip and shoulder girdle, elevated CRP and ESR, and normal creatine kinase levels 4, 5
  • Muscle vasculitis, which may be an underlying pathology in PMR, particularly in refractory cases 4
  • Adult-onset Still's disease (AOSD), a condition that may mimic myositis and is characterized by severe myalgia, progressive weakness, and elevated serum ferritin levels 6

Laboratory Tests and Diagnostic Criteria

Laboratory tests and diagnostic criteria for myalgia may vary depending on the underlying condition.

  • Elevated CRP and ESR levels are common in many conditions that cause myalgia, including PMR and AOSD 3, 4, 6, 5
  • Normal creatine kinase levels are characteristic of PMR, while elevated creatine kinase levels may be seen in other conditions such as post-infection myositis 2, 3, 5
  • Muscle biopsy and electromyography may be useful in diagnosing specific muscle abnormalities, such as muscle vasculitis or inflammatory myopathy 2, 3, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Investigative strategies for muscle pain.

Journal of the neurological sciences, 1983

Research

[Polymyalgia rheumatica].

Nihon rinsho. Japanese journal of clinical medicine, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.